The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Treeman remember when you used to ramp SCE ON THIS BOARD when it was 70p, where is it now 3p. You used to praise the DCE board.. you don't have a clue do you?
Hey Treeman I remember you pumping Surface transforms on HERE when they were 70 p, you're certainly a man to take notice of
But wait SCE is only 11 p now, perhaps you're not so smart, perhaps people should be warned, you haven't a clue.
Twogood
The only difference between UK shares and US ADRs is that the shares are bundled in lots of 10. The shares in ADRs are genuine AGL shares and have been transferred to the US via a bank as a block transfer. They are bought and sold just like any other share in the US
Treeman. You'd be better off trying to rally support on the Surface transforms board, it looks to be in a bit of a hole. Remember how you used to ramp that stock on here. No one really takes notice of your comments here it's the same old broke record.
Who in their right mind, looking for a business bank account or a mortgage would choose NatWest after the way they have treated and continue to treat customers. I can only see future business slowing for NatWest
Jelenko. Parsortix can not analyse CtDNA, and you know it, you've been pulled up on this misinformation several times before. In fact Parsortix can't even Analyse CTCs, all it does is capture them for Analysis down the line by using other technology. Parsortix in fundamental terms is a filter. And before you claim that Parsortix can capture CtDNA, that also is not the case. Although the blood sample that has passed throught the Parsortix machine can be passed on for CtDNA analysis by whatever system is available.